Unknown

Dataset Information

0

Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study.


ABSTRACT: Retrospective data suggest that cryptococcal antigen (CrAg) screening in patients with late-stage human immunodeficiency virus (HIV) initiating antiretroviral therapy (ART) may reduce cryptococcal disease and deaths. Prospective data are limited.CrAg was measured using lateral flow assays (LFA) and latex agglutination (LA) tests in 645 HIV-positive, ART-naive patients with CD4 counts ?100 cells/µL in Cape Town, South Africa. CrAg-positive patients were offered lumbar puncture (LP) and treated with antifungals. Patients were started on ART between 2 and 4 weeks and followed up for 1 year.A total of 4.3% (28/645) of patients were CrAg positive in serum and plasma with LFA. These included 16 also positive by urine LFA (2.5% of total screened) and 7 by serum LA (1.1% of total). In 4 of 10 LFA-positive cases agreeing to LP, the cerebrospinal fluid (CSF) CrAg LFA was positive. A positive CSF CrAg was associated with higher screening plasma/serum LFA titers.Among the 28 CrAg-positive patients, mortality was 14.3% at 10 weeks and 25% at 12 months. Only 1 CrAg-positive patient, who defaulted from care, died from cryptococcal meningitis (CM). Mortality in CrAg-negative patients was 11.5% at 1 year. Only 2 possible CM cases were identified in CrAg-negative patients.CrAg screening of individuals initiating ART and preemptive fluconazole treatment of CrAg-positive patients resulted in markedly fewer cases of CM compared with historic unscreened cohorts. Studies are needed to refine management of CrAg-positive patients who have high mortality that does not appear to be wholly attributable to cryptococcal disease.

SUBMITTER: Longley N 

PROVIDER: S-EPMC4741358 | biostudies-other | 2016 Mar

REPOSITORIES: biostudies-other

altmetric image

Publications

Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study.

Longley Nicky N   Jarvis Joseph Nicholas JN   Meintjes Graeme G   Boulle Andrew A   Cross Anna A   Kelly Nicola N   Govender Nelesh P NP   Bekker Linda-Gail LG   Wood Robin R   Harrison Thomas S TS  

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20151112 5


<h4>Background</h4>Retrospective data suggest that cryptococcal antigen (CrAg) screening in patients with late-stage human immunodeficiency virus (HIV) initiating antiretroviral therapy (ART) may reduce cryptococcal disease and deaths. Prospective data are limited.<h4>Methods</h4>CrAg was measured using lateral flow assays (LFA) and latex agglutination (LA) tests in 645 HIV-positive, ART-naive patients with CD4 counts ≤100 cells/µL in Cape Town, South Africa. CrAg-positive patients were offered  ...[more]

Similar Datasets

| S-EPMC5625589 | biostudies-literature
| S-EPMC8263144 | biostudies-literature
| S-EPMC3432418 | biostudies-literature
| S-EPMC4832364 | biostudies-literature
2010-08-11 | GSE19442 | GEO
| S-EPMC8257409 | biostudies-literature